APA (7th ed.) Citation

Song, E. M., Seo, G. H., & Jung, S. H. (2025). Long-Term Safety of Tofacitinib for Treatment of Moderate-to-Severe Ulcerative Colitis: Three Years of Korean National Data. Journal of Korean medical science, 40(39), e259-9. https://doi.org/10.3346/jkms.2025.40.e259

Chicago Style (17th ed.) Citation

Song, Eun Mi, Gi Hyeon Seo, and Sung Hoon Jung. "Long-Term Safety of Tofacitinib for Treatment of Moderate-to-Severe Ulcerative Colitis: Three Years of Korean National Data." Journal of Korean Medical Science 40, no. 39 (2025): e259-9. https://doi.org/10.3346/jkms.2025.40.e259.

MLA (9th ed.) Citation

Song, Eun Mi, et al. "Long-Term Safety of Tofacitinib for Treatment of Moderate-to-Severe Ulcerative Colitis: Three Years of Korean National Data." Journal of Korean Medical Science, vol. 40, no. 39, 2025, pp. e259-9, https://doi.org/10.3346/jkms.2025.40.e259.